You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽普醫療(300030.SZ)2019年度業績扭虧為盈至2602.42萬元
格隆匯 03-06 20:25

格隆匯3月6日丨陽普醫療(300030.SZ)披露2019年年度報告,實現營業收入5.75億元,同比增長4.56%;歸屬於上市公司股東的淨利潤2602.42萬元,上年度則為淨虧損1.37億元;基本每股收益0.08元,公司計劃不派發現金紅利,不送紅股,不以公積金轉增股本。

上年虧損的原因主要是2018年公司子公司未能達成業績原有預期,計提了大額商譽減值。本報告期內,公司聚焦主營產品的推廣和銷售,主營業務穩定增長,營業收入與去年同期增長4.56%

陽普醫療是國內真空採血系統行業的龍頭企業,是國內臨牀檢驗實驗室標本分析前變異控制技術的領軍者。經過二十多年的發展,公司近三百名研發技術人員形成了五個專業團隊和一個公用平台,即廣東省醫用材料血液相容性企業重點實驗室、止血凝血產品線研究中心、免疫學產品線研究中心、分子診斷產品線團隊、醫療信息化產品線團隊和有源無源醫療器械研究公用平台。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account